Andrew Proudfoot

No ORCID on file · 6 papers in corpus · active 2022-2025

Study types

  • preprint 3
  • article 2
  • other 1

Condition tags

  • endometriosis 6
  • mesh:D004715 3
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • mesh:D017699 1
preprint 2025
“A dose of relief?”: Results of an international survey exploring self-reported effectiveness, dose and dosage forms of cannabis for endometriosis pain and related symptoms
·doi:10.21203/rs.3.rs-6910005/v1
preprint 2025
Damned if you do, damned if you don’t? Misrepresentation and fraudulent non-disclosure consequences of Australians with endometriosis not disclosing cannabis use to life insurers.
·doi:10.31219/osf.io/23ys9_v1

People with endometriosis in Australia predominantly use delta-9 tetrahydrocannabinol cannabis flower and oil products, and cannabidiol preparations, to manage their symptoms, reporting reductions in use of other drugs. It is known that low…

preprint 2025
Insurance, Endometriosis and the use of medicinal cannabis in Australia: A qualitative analysis
·doi:10.21203/rs.3.rs-6083910/v1
article 2024
A survey of cost, access and outcomes for cannabinoid‐based medicinal product use by Australians with endometriosis
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13804

People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self-reported effectiveness for those accessing medicinal cannabis in Australia. There we…

article 2023
The Place of Cannabinoids in the Treatment of Gynecological Pain
Drugs ·doi:10.1007/s40265-023-01951-z

Cannabis sativa (L), a plant with an extensive history of medicinal usage across numerous cultures, has received increased attention over recent years for its therapeutic potential for gynecological disorders such as endometriosis, chronic …

other 2022
Endometriosis and Cannabis Consumption During the COVID-19 Pandemic: An International Cross-Sectional Survey
Cannabis and cannabinoid research ·doi:10.1089/can.2021.0162

Introduction: Endometriosis affects 1 in 10 women worldwide, with most experiencing difficulties achieving adequate symptom control. These difficulties have been compounded by the onset of the COVID-19 pandemic due to worldwide shifts in he…